biomedcentral.com/bmcpharmacoltoxicol/article
Bottom,Top,Right1
  • Welcome Stanford University
  • Log on
  •   BioMed Central
  • Journals
  • Gateways
BMC Pharmacology and Toxicology
unofficial impact factor 3.15
Search for
Advanced search
  • Home
  • Articles
  • Authors
  • Reviewers
  • About this journal
  • My BMC Pharmacology and Toxicology

Submit a manuscript Register Sign up for article alerts Contact us Follow us on Twitter

Explore journal

  •  Editorial Board
  •  Instructions for authors
  •  FAQ
Advertisement

Articles

  • All articles RSS
  • Sections
  • Most viewed RSS
  • Archive
  • Supplements
Drug design, discovery and delivery Section edited by Giorgio Palu

This section considers submissions that focus on research relating to novel chemical entity design, screening and delivery.

Page 1 of 1

 Display/download options Articles per page: 25 | 50 | 100

Display options
Download optionsHelp icon

1.

Research article   Open Access

Tocopheryl acetate 20% spray for elimination of head louse infestation: a randomised controlled trial comparing with 1% permethrin creme rinse

Ian F Burgess, Nazma A Burgess, Elizabeth R Brunton BMC Pharmacology and Toxicology 2013, 14:43 (3 September 2013)

Abstract | Full text | PDF | PubMed

2.

Research article   Open Access Highly Accessed

Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF rats

Nagesh Gowda, Anilkumar Dandu, Jaideep Singh, Sanghamitra Biswas, Vijaya Raghav, Mudigere N Lakshmi, Pavagada C Shilpa, Venkategowda Sunil, Ashokkumar Reddy, Manojkumar Sadasivuni, Kumaraswamy Aparna, Mahesh Verma, Yoganand Moolemath, Mammen O Anup, Marikunte V Venkataranganna, Baggavalli P Somesh, Madanahalli R Jagannath BMC Pharmacology and Toxicology 2013, 14:28 (21 May 2013)

Abstract | Full text | PDF | ePUB | PubMed |  Editor’s summary

Rats treated with CNX-011-67 demonstrate improved glucose mediated insulin secretion and insulin gene transcription, enhanced glucose oxidation in the form of increased islet ATP content and overall improvement in beta cell health.

3.

Research article   Open Access

Pharmaceutical quality of seven generic Levodopa/Benserazide products compared with original Madopar® / Prolopa®

Urs E Gasser, Anton Fischer, Jan P Timmermans, Isabelle Arnet BMC Pharmacology and Toxicology 2013, 14:24 (23 April 2013)

Abstract | Full text | PDF | ePUB | PubMed

Page 1 of 1


  • Terms and Conditions
  • Privacy statement
  • Press
  • Information for advertisers
  • Jobs at BMC
  • Support
  • Contact us

© 2013 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.